ObsEva SA (OBSV)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

CHEMIN DES AULX, 12 PLAN-LES-OUATES, SWITZERLAND 1228

ObsEva SA operates as a clinical-stage biopharmaceutical company. The Company focuses on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. ObsEva serves customers worldwide.

Data based on most recent fiscal year report
Market Cap490.487 Million Shares Outstanding37.13 Million Avg Volume77.578 Thousand
1-Yr BETA vs S&P TR1.555 Current Ratio11.99 Quick Ratio11.99
View SEC Filings from OBSV instead.
Q2 2019 All Institutions Hedge Funds 1
To trade OBSV now:
Filers who had this stock in their top 10: 8 2 (0.21%)
13F Filers holding this stock: 55 13 (1.34%)
Aggregate 13F shares on 06/30/2019: 29.085 Million 9.122 Million
Aggregate 13F shares on 03/31/2019: 28.908 Million 9.437 Million
Percent change: 0.62% -3.33%
Funds creating new positions: 2 1
Funds Adding to an existing position: 20 4
Funds closing out their position: 5 5
Funds reducing their position: 8 1
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding OBSV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments